DI STEFANO, Antonio
 Distribuzione geografica
Continente #
NA - Nord America 5.751
EU - Europa 5.353
AS - Asia 2.742
Continente sconosciuto - Info sul continente non disponibili 10
SA - Sud America 10
AF - Africa 6
OC - Oceania 1
Totale 13.873
Nazione #
US - Stati Uniti d'America 5.708
IT - Italia 1.243
CN - Cina 983
SG - Singapore 933
IE - Irlanda 856
UA - Ucraina 778
SE - Svezia 606
GB - Regno Unito 588
TR - Turchia 528
FR - Francia 478
DE - Germania 322
IN - India 218
FI - Finlandia 168
RU - Federazione Russa 135
BE - Belgio 44
CA - Canada 38
CZ - Repubblica Ceca 34
VN - Vietnam 28
IR - Iran 19
AT - Austria 18
HK - Hong Kong 18
PL - Polonia 14
ES - Italia 13
GR - Grecia 11
EU - Europa 10
LT - Lituania 8
NL - Olanda 7
CH - Svizzera 6
BR - Brasile 5
DK - Danimarca 4
RO - Romania 4
AE - Emirati Arabi Uniti 3
AR - Argentina 3
JP - Giappone 3
PA - Panama 3
PT - Portogallo 3
AL - Albania 2
AZ - Azerbaigian 2
CL - Cile 2
HU - Ungheria 2
KR - Corea 2
MA - Marocco 2
NO - Norvegia 2
TN - Tunisia 2
BG - Bulgaria 1
EE - Estonia 1
EG - Egitto 1
HR - Croazia 1
ID - Indonesia 1
IL - Israele 1
JM - Giamaica 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
ME - Montenegro 1
MM - Myanmar 1
MT - Malta 1
MX - Messico 1
NZ - Nuova Zelanda 1
TH - Thailandia 1
ZA - Sudafrica 1
Totale 13.873
Città #
Chandler 1.123
Jacksonville 928
Singapore 845
Dublin 844
Southend 460
Princeton 373
Chieti 327
Izmir 298
Nanjing 265
Ashburn 233
Dearborn 228
Ann Arbor 200
Santa Clara 189
Wilmington 175
Cambridge 146
Altamura 143
Beijing 123
Nanchang 95
Boardman 87
New York 83
Shenyang 67
Woodbridge 53
Tianjin 52
Los Angeles 51
Munich 50
Hebei 48
Kunming 48
Pescara 48
Brussels 44
Washington 42
Brno 31
Helsinki 31
Jinan 30
Grevenbroich 29
Kocaeli 29
Rome 29
Dong Ket 28
Falls Church 26
Jiaxing 26
Zhengzhou 26
Leawood 25
Milan 22
Hangzhou 20
Houston 20
San Mateo 20
Augusta 19
Ningbo 19
Norwalk 19
Seattle 19
Changsha 16
Vienna 16
Bologna 15
Guangzhou 15
Lanciano 15
Ancona 14
Ardabil 14
Auburn Hills 14
Lanzhou 14
Silvi 14
Toronto 14
Hong Kong 13
Teramo 13
Kraków 12
Moscow 11
Orange 11
Changchun 10
Düsseldorf 10
Isernia 10
L'aquila 10
London 10
Orsogna 10
Romola 10
Santa Maria Imbaro 10
Simi Valley 10
Taizhou 9
Villaverla 9
Frankfurt am Main 8
Monmouth Junction 8
Bari 7
Campomarino 7
Edinburgh 7
Hefei 7
Ottawa 7
San Jose 7
Wuhan 7
Catania 6
Erzurum 6
Laval 6
Serra 6
Tappahannock 6
Ascoli Piceno 5
Bonn 5
Haikou 5
Nashville 5
Perugia 5
Pune 5
Sacramento 5
Shanghai 5
Cedar Knolls 4
Cepagatti 4
Totale 8.608
Nome #
Viscoelastic properties of Staphylococcus aureus and Staphylococcus epidermidis mono-microbial biofilms 175
Development of glycine-α-methyl-proline-containing tripeptides with neuroprotective properties 135
Chelating and antioxidant properties of l-Dopa containing tetrapeptide for the treatment of neurodegenerative diseases 133
Synthesis of a novel cyclic prodrug of S -allyl-glutathione able to attenuate LPS-induced ROS production through the inhibition of MAPK pathways in U937 cells 132
Modulation of apoptotic cell death and neuroprotective effects of glutathione—L-Dopa codrug against H2O2-induced cellular toxicity 126
Gold nanoparticles as scaffolds for poor water soluble and difficult to vehiculate antiparkinson codrugs 126
Sintesi e valutazione dell’attività antimicrobica di nuovi carvacrolo codrugs 120
Memantine-derived drugs as potential antitumor agents for the treatment of glioblastoma 118
Synthesis of a novel TRH-related sulphonamido peptide 115
Solid lipid nanoparticles loaded with lipoyl-memantine codrug: preparation and characterization 114
(R)-α-Lipoyl-Gly-L-Pro-L-Glu dimethyl ester as dual acting agent for the treatment of Alzheimer's disease 114
Zingiberene attenuates hydrogen peroxide-induced toxicity in neuronal cells 113
Preparation and characterization of polymeric micelles loaded with a potential anticancer prodrug 113
Preparation of boronate derivatives for the treatment of diseases and conditions associated to oxidative stress 113
NSAID Coniugates for the treatment of Alzheimer's Disease 111
A glutathione derivative with chelating and in vitro neuroprotective activities: synthesis, physicochemical properties, and biological evaluation. 109
Sintesi di trans-2-ammino-5(o 6)-cloro-6(o 5)-idrossi-1-fenil-2,3-diidro-1H-indani quali precursori di derivati a potenziale affinità per i recettori della dopamina 108
Synthesis and evaluation of trans-2-amino-5(or 6)-chloro-6(or 5)-hydroxy-1-phenyl-2,3-dihydro-1H-indenes as dopamine receptor ligands 106
Synthesis and preliminary pharmacological evaluation of 2,3,4,8,13a-hexahydro-1H-benzo(5,6)cyclohepta(1,2,3-ef)(3)benzazepine-6,7-diol derivatives as dopamine receptor ligands 105
(R)-α-Lipoyl-glycyl-L-prolyl-L-glutamyl dimethyl ester codrug as a multifunctional agent with potential neuroprotective activities 105
Single-Walled Carbon Nanotubes in Highly Viscous Media: A Comparison between the Dispersive Agents [BMIM][BF4], L121, and Triton X-100 103
Cofarmaci L-Dopa-antiossidanti solforati quali nuovi potenziali agenti anti-Parkinson 102
Toxicity assessment of hydroxyapatite nanoparticles in rat liver cell model in vitro 102
Synthesis and biological evaluation of novel analogues of Gly-l-Pro-l-Glu (GPE) as neuroprotective agents 102
Antiparkinson Prodrugs 102
Characterization of alkanoyl-10-O-minocyclines in micellar dispersions as potential agents for treatment of human neurodegenerative disorders 101
Carvacrol codrugs: A new approach in the antimicrobial plan 100
sintesi ed attività di due analoghi del glutatione a conformazione ristretta 98
Ibuprofen and glutathione conjugate as a potential therapeutic agent for treating Alzheimer's disease 98
Synthesis and preliminary pharmacological evaluation of 5-hydroxy and 5,6-dihydroxy-benzo(5,6)cyclohept(1,2,3-ij)isoquinoline derivatives as dopamine receptor ligands 97
Effect of MRJF4 on C6 glioma cells proliferation and migration 97
Carvacrol prodrugs as novel antimicrobial agents 97
Potential Antibacterial Activity of Carvacrol-Loaded PLGA Nanoparticles against Microbial Biofilm 97
Advances in prodrug design for Parkinson's disease 97
L-dopa co-drugs in nanostructured lipid carriers: A comparative study 96
CNS delivery of L-Dopa by a new Hybrid Glutathione-Methionine peptidomimetic prodrug 95
Temporal expression of agrB, cidA and alsS in the early development of Staphylococcus aureus UAMS-1 biofilm formation and the structural role of extracellular DNA and carbohydrates 95
Health risk assessments of lithium titanate nanoparticles in rat liver cell model for its safe applications in nanopharmacology and nanomedicine 95
Sintesi di trans-2-ammino-1-fenil-5-fluoro-6-idrossi (e 6-fluoro-5-idrossi)-2,3-diidro-1H-indeni quali potenziali ligandi per i recettori dopaminergici 94
A novel TRH analog containing a gamma-sultam residue replacing the pyroglutamic acid 94
Au nanoparticles functionalized by newly synthetised antiparkinson prodrugs 94
Synthesis and antioxidant properties of novel memantine derivatives 94
Synthesis and preliminary evaluation of L-dopa/benserazide conjugates as dual acting codrugs 92
“Evaluation of endocrine disruptors, TPHPand DPHP, effect on DNA repair damage pathwais in a normal human thyroid cell model” 92
Synthesis and Study of L-Dopa-Glutathione Codrugs as New Anti-Parkinson Agents with Free Radical Scavenging Properties. 91
synthesis and Activity of L-Dopa-Thiol antioxidant Co-drugs and New anti-PArkinson Agents with free Radical Scavenging Properties 91
L-Dopa Prodrugs: An Overview of Trends for Improving Parkinson's Disease Treatment 91
Novel NSAID-derived drugs for the potential treatment of Alzheimer’s disease 91
Carvacrol and its derivatives as antibacterial agents 91
Design, synthesis and preliminary pharmacological evaluation of new imidazolinones as L-DOPA prodrugs. 90
Gold nanoparticles as scaffolds for new antiparkinson prodrugs 90
Synthesis and Biological Evaluation of Novel Selenyl and Sulfur-l-Dopa Derivatives as Potential Anti-Parkinson's Disease Agents 90
Synthesis of a novel glutathione analogue as potential inhibitor of glutathione-S-transferase 88
Binding and preliminary evaluation of 5-hydroxy- and 10-hydroxy-2,3, 12,12a-tetrahydro-1H-[1]benzoxepino[2,3,4-ij]isoquinolines as dopamine receptor ligands. 88
Biodegradable microspheres loaded with an antiparkinson prodrug: an in vivo pharmacokinetic study 88
Maleic- and Fumaric-diamides of (O,O-diacetyl)-L-Dopa-methylester as anti-Parkinson prodrugs in liposomal formulation 87
HPLC–FLD and spectrofluorometer apparatus: How to best detect fluorescent probe-loaded niosomes in biological samples 87
Direct- and spacer-coupled codrug strategies for the treatment of Alzheimer’s disease 86
Synthesis and preliminary pharmacological evaluation of trans-2-amino-5(6)-chloro-6(5)-hydroxy-1- phenyl-2,3-dihydro-1H-indenes as dopamine receptor ligands 86
Novel hydrogel and functionalized silica for dispersion of CO2 and carbon nanotube-based catalysts 86
RNAIII Inhibiting Peptide (RIP) and derivatives as potential tools for the treatment of S. aureus biofilm infections 86
synthesis and biological evaluation as anti-Parkinson agent of an analogue of Glutathione-L-Dopa containing methionine in place of the cysteinil residue 85
Solid lipid nanoparticles as a drug delivery system for the treatment of neurodegenerative diseases 85
Synthesis and biological evaluation of a novel pyroglutamil-modified TRH analogue 84
Activity of N-(2-phenylethyl)-N-n-propyl-(2-(3-hydroxyphenyl)ethylamine derivates as dopamine receptor ligands 84
Role of Dietary Supplements in the Management of Parkinson's Disease 84
Ibuprofen and lipoic acid diamide as co-drugs with neuroprotective activity: pharmacological properties and effects in β-amyloid (1-40) infused Alzheimer’s disease rat model. 83
NOS-mediated morphological and molecular modifications in rats infused with Aβ (1-40), as a model of Alzheimer’s Disease, in response to a new lipophilic molecular combination codrug-1 83
Memantine-sulphur containing antioxidant conjugates as potential prodrugs to improve the treatment of Alzheimer’s disease 83
Novel hydrogels for dispersion of carbon nanotube-based catalysts 83
In vitro evaluation of the potential anticancer activity of new memantin co-drugs on rat C6 glioblastoma cells 83
Synthesis of l-(+)-3-(3-hydroxy-4-pivaloyloxybenzyl)-2,5-diketomorpholine as potential prodrug of l-dopa 83
Epigenetic Memory of Early-Life Parental Perturbation: Dopamine Decrease and DNA Methylation Changes in Offspring 83
Viscoelastic behaviour of hyaluronic acid formulations containing carvacrol prodrugs with antibacterial properties 83
Twin amides as potential prodrugs of L-DOPA 82
A new lipophilic molecular combination codrug-1 exerts neuroprotective activity in beta amyloid (1-40) infused Alzheimer’s disease rat model 82
Nuovi S-coniugati del glutatione ad attività inibitoria nei confronti delle GST umane 81
Synthesis and evalutation of N-n-propyl-N-(2-phenylethyl)-2-(3-fluoro-4-hydroxy-phenyl) ethylamine derivatives 81
Stimulation of Human Macrophages (THP-1) using Toll-like Receptor-2 (TLR-2) Agonist Decorated Nanocarriers 81
Novel hydrogels for dispersion of carbon nanotube-based catalysts 81
Synthesis, characterization and evaluation of gemfibrozil-stilbene hybrid as antioxidant agent 81
Transition state isosteres of the gamma-glutamyl peptide bond hydrolysis: synthesis and characterization of the psi (CH2NH) pseudopeptide analogue of glutathione 81
Synthesis and evalutation of 2-(5-methoxythiophen-3-yl)ethylamines as potential dopamine agonists 80
Evaluation of 2,3,4,8,13a hexahydro-1H-Benzo[5,6]cyclohepta-6,7-dihydroxy[1,2,3-ef][3]benzazepine derivatives as dopamine receptor ligands 80
Evaluation of rat striatal L-Dopa and DA concentration after intraperitoneal administration of L- Dopa prodrugs in liposomal formulations 80
New drug delivery strategies for improved Parkinson’s disease therapy 80
Codrugs Linking l-Dopa and Sulfur-Containing Antioxidants: New Pharmacological Tools against Parkinson’s Disease 79
Design and synthesis of multifunctional drugs: a strategy to improve the treatment of Parkinson’s disease 79
Preparation and pharmacological characterization of trans-2-amino-5(6)-fluoro-6(5)-hydroxy-1-phenyl-2,3-dihydro-1H-indenes as D2-like dopamine receptor agonists 79
MRJF4, a novel histone deacetylase inhibitor, induces p21 mediated autophagy in PC3 prostate cancer cells 78
Novel anti-Alzheimer phenol-lipoyl hybrids: Synthesis, physico-chemical characterization, and biological evaluation 78
Glycosyl and polyalcoholic prodrugs of lonidamine 77
Inside Cover: Single-Walled Carbon Nanotubes in Highly Viscous Media: A Comparison between the Dispersive Agents [BMIM][BF4 ], L121, and Triton X-100 (Chem. Eur. J. 2/2016) 77
Detection of levodopa, dopamine and its metabolites in rat striatum dialysates following peripheral administration of L-DOPA prodrugs by mean of HPLC-EC 76
Ibuprofen and lipoic acid diamides as potential codrugs with neuroprotective activity 76
Evidence for a Dopamine Intrinsic Direct Role in the Regulation of the Ovary Reproductive Function: In Vitro Study on Rabbit Corpora Lutea 76
Graphene Oxide increases mammalian spermatozoa fertilizing ability by extracting cholesterol from their membranes and promoting capacitation 76
Natural oxyprenylated coumarins are modulators of melanogenesis 76
Synthesis and activity of novel glutathione analogues containing an urethane backbone linkage 75
Designing Prodrugs for the Treatment of Parkinson's Disease 75
Totale 9.365
Categoria #
all - tutte 58.040
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.040


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.285 0 0 0 0 0 215 342 205 66 206 207 44
2020/20211.198 166 13 183 27 87 214 31 24 92 151 136 74
2021/2022918 33 32 13 94 93 33 34 61 131 42 89 263
2022/20233.067 235 464 178 332 280 584 153 281 367 47 66 80
2023/20241.486 99 82 102 54 94 461 318 55 20 24 27 150
2024/20251.923 192 720 616 122 50 223 0 0 0 0 0 0
Totale 14.442